Details for New Drug Application (NDA): 072417
✉ Email this page to a colleague
NDA 072417 describes SULFAMETHOXAZOLE AND TRIMETHOPRIM DOUBLE STRENGTH, which is a drug marketed by Fosun Pharma, Heritage Pharma Avet, Martec Usa Llc, Mutual Pharm, Roxane, and Watson Labs, and is included in six NDAs. Additional details are available on the SULFAMETHOXAZOLE AND TRIMETHOPRIM DOUBLE STRENGTH profile page.
The generic ingredient in SULFAMETHOXAZOLE AND TRIMETHOPRIM DOUBLE STRENGTH is sulfamethoxazole; trimethoprim. There are twenty-seven drug master file entries for this compound. Forty-eight suppliers are listed for this compound. Additional details are available on the sulfamethoxazole; trimethoprim profile page.
The generic ingredient in SULFAMETHOXAZOLE AND TRIMETHOPRIM DOUBLE STRENGTH is sulfamethoxazole; trimethoprim. There are twenty-seven drug master file entries for this compound. Forty-eight suppliers are listed for this compound. Additional details are available on the sulfamethoxazole; trimethoprim profile page.
Summary for 072417
| Tradename: | SULFAMETHOXAZOLE AND TRIMETHOPRIM DOUBLE STRENGTH |
| Applicant: | Martec Usa Llc |
| Ingredient: | sulfamethoxazole; trimethoprim |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 800MG;160MG | ||||
| Approval Date: | Dec 7, 1988 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
